Squarepoint’s AngioDynamics ANGO Stock Holding History

Squarepoint’s Portfolio ANGO Stock Details ANGO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$1.07M	Buy	93,787 +52,684	+128%	+$571K	﹤0.01%	2727
2025 Q4	$528K	Sell	41,103 -123,250	-75%	-$1.52M	﹤0.01%	3174
2025 Q3	$1.84M	Buy	164,353 +78,657	+92%	+$759K	﹤0.01%	2174
2025 Q2	$850K	Buy	85,696 +18,879	+28%	+$185K	﹤0.01%	2808
2025 Q1	$627K	Buy	66,817 +24,559	+58%	+$258K	﹤0.01%	3084
2024 Q4	$387K	Buy	+42,258	New	+$311K	﹤0.01%	3954
2024 Q2	–	Sell	-27,494	Closed	-$161K	–	4020
2024 Q1	$161K	Sell	27,494 -7,406	-21%	-$44K	﹤0.01%	3684
2023 Q4	$274K	Sell	34,900 -121,024	-78%	-$839K	﹤0.01%	3423
2023 Q3	$1.14M	Buy	155,924 +122,726	+370%	+$1.02M	﹤0.01%	2229
2023 Q2	$346K	Buy	33,198 +15,653	+89%	+$151K	﹤0.01%	2878
2023 Q1	$181K	Sell	17,545 -108,849	-86%	-$1.39M	﹤0.01%	2840
2022 Q4	$1.74M	Buy	126,394 +96,906	+329%	+$1.35M	0.01%	1445
2022 Q3	$603K	Buy	+29,488	New	+$647K	﹤0.01%	2110
2022 Q2	–	Sell	-13,527	Closed	-$291K	–	2856
2022 Q1	$291K	Buy	13,527 +2,467	+22%	+$56K	﹤0.01%	2296
2021 Q4	$305K	Buy	+11,060	New	+$305K	﹤0.01%	2443
2021 Q3	–	Sell	-28,183	Closed	-$765K	–	2873
2021 Q2	$765K	Sell	28,183 -35,881	-56%	-$876K	﹤0.01%	1829
2021 Q1	$1.5M	Buy	64,064 +36,252	+130%	+$733K	0.01%	1250
2020 Q4	$426K	Sell	27,812 -15,817	-36%	-$201K	﹤0.01%	1928
2020 Q3	$526K	Buy	43,629 +1,178	+3%	+$11.2K	0.01%	1398
2020 Q2	$432K	Sell	42,451 -10,464	-20%	-$108K	0.01%	1385
2020 Q1	$552K	Sell	52,915 -58,862	-53%	-$739K	0.01%	981
2019 Q4	$1.79M	Buy	111,777 +85,275	+322%	+$1.3M	0.01%	972
2019 Q3	$488K	Sell	26,502 -86,213	-76%	-$1.69M	﹤0.01%	1629
2019 Q2	$2.22M	Buy	112,715 +102,135	+965%	+$2.08M	0.02%	785
2019 Q1	$242K	Buy	+10,580	New	+$230K	﹤0.01%	1869
2017 Q4	–	Sell	-28,913	Closed	-$494K	–	2063
2017 Q3	$494K	Buy	+28,913	New	+$486K	0.01%	981
2017 Q1	–	Sell	-13,841	Closed	-$233K	–	1507
2016 Q4	$233K	Buy	+13,841	New	+$231K	0.01%	1319

Other funds holding ANGO

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return

SFM

Systematic Financial Management Teaneck, New Jersey $4.36B AUM 40.56% 1-Year Est. Return

Broadfin Holdings Melville, New York $23.5M AUM

Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return

WCM

Weber Capital Management San Francisco, California $100M AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

BAM

Bastion Asset Management Montreal, Canada $328M AUM 13.57% 1-Year Est. Return

Squarepoint's ANGO Position: Q1 2026 in Review

Squarepoint increased its AngioDynamics (ANGO) stake by 128% in Q1 2026, buying an estimated $571K and bringing the position to 93,787 shares worth $1.07M. The position accounts for ﹤0.01% of the portfolio, ranked #2727.

Squarepoint first reported a position in ANGO in Q4 2016 and has held it in 27 quarters since. The position peaked at $2.22M in Q2 2019. 147 funds tracked by Wall St. Rank hold ANGO as of Q1 2026.

Squarepoint held 93,787 shares of AngioDynamics worth $1.07M as of Q1 2026.
Squarepoint bought 52,684 AngioDynamics shares in Q1 2026, an estimated $571K.
AngioDynamics made up ﹤0.01% of Squarepoint's portfolio in Q1 2026, its #2727 holding.
Squarepoint first reported a position in AngioDynamics in Q4 2016 and has held it in 27 quarters since.
Squarepoint's AngioDynamics position peaked at $2.22M in Q2 2019.
147 funds tracked by Wall St. Rank held AngioDynamics as of Q1 2026.

Based on Squarepoint's 13F filing for Q1 2026, filed 15 May 2026.